Retrospective cohort study on risk factors for developing ischemic stroke

Main Article Content

Keywords

Ischemic stroke, Model, Modifiable and non-modifiable, Predictors, Risk factors

Abstract

Background: There is a paucity of studies describing the risk factors for developing ischemic stroke in our region. Objective: The objective of the current study was to delineate the potential risk factors for the development of ischemic stroke. Methods: We have conducted a retrospective cohort hospitalbased study that has enrolled 231 subjects. The subjects have had presented to the emergency department in a tertiary hospital in the United Arab Emirates. Subjects were diagnosed with ischemic stroke within 24 hours of presentation. Outcome measure: The main outcome measure was the development of ischemic stroke during an indexed hospital visit. Results: The mean age was 47.5 ±3.2 with a higher preponderance of males over females (60.9%) and 48.1% were ≥ 65 years. The final logistic regression model for the development of ischemic stroke contains seven variables. In descending order, the seven predictive risk factors for the development of ischemic stroke were: hypertension (OR 6.1, CI 2.4-9.5; P = 0.029), coronary artery disease (OR 4.2, 3.7-9.1; P = 0.038), low physical activity (OR 4.2, CI 2.1-9.1; P = 0.035), history of previous stroke (OR 4.1, 1.4-3.4; P = 0.033), atrial fibrillation (OR 3.2, CI 2.6-8.2; P = 0.017), family history of stroke (OR 3.1, 1.3-6.9; P = 0.042) and diabetes mellitus (OR 2.7, CI 1.25-6.1; P = 0.035). The specificity of the model was 58.1%; the sensitivity was 86.1%, and the overall accuracy was 75.7%. Conclusion: It is prudent to control modifiable risk factors for the development of strokes such as hypertension, diabetes, atrial fibrillation, coronary artery disease, and low physical activity.

Downloads

Download data is not yet available.
Abstract 372 | PDF Downloads 270

References

1. Global Burden of Diseases (GBD). Mortality and Causes of Death Collaborators. Global, regional, and national age–sexspecific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the G lobal Burden
of Disease Study 2013. Lancet. 2015;385(9963):117-171. https://doi.org/10.1016/S0140-6736(14)61682-2
2. Feigin VL, Krishnamurthi RV, Parmar P, et al. Global Burden of Diseases (GBD). 2013 Writing Group; GBD 2013 Stroke
Panel Experts Group. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-176. https://doi.org/10.1159/000441085
3. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521-1526. https://doi.org/10.1016/0140-6736(91)93206-o
4. Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015;45(3):203-214. https://doi.org/10.1159/000441103
5. Lloyd-Jones D, Adams R, Carnethon M, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-181. https://doi.org/10.1161/CIRCULATIONAHA.108.191259
6. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics
Subcommittee. Heart disease and stroke statistics–-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292. https://doi.org/10.1161/01.cir.0000441139.02102.80
7. Krishnamurthi RV, Moran AE, Feigin VL, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015;45(3):190-202. https://doi.org/10.1159/000441098
8. Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population.  Neurology. 2012;79(17):1781-1787. https://doi.org/10.1212/WNL.0b013e318270401d
9. George MG, Tong X, Kuklina EV, et al. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol. 2011;70(5):713-721. https://doi.org/10.1002/ana.22539
10. Williams PT. Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the National Runners’ Health Study. Stroke. 2009;40(5):1921-1923. https://doi.org/10.1161/STROKEAHA.108.535427
11. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006;367(9524):1747-1757. https://doi.org/10.1016/S0140-6736(06)68770-9
12. Flossmann E, Schulz U, Rothwell P. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35(1):212-227.
13. Scarborough P, Morgan RD, Webster P, et al. Differences in coronary heart disease, stroke and cancer mortality rates between
England, Wales, Scotland and Northern Ireland: the role of diet and nutrition. BMJ Open. 2011;1(1):e000263. https://doi.
org/10.1136/bmjopen-2011-000263
14. O’Donnell MJ, Chin SL, Rangarajan S, et al. INTERSTROKE Investigators. Global and regional effects of poten- tially modifiable
risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-
775. https://doi.org/10.1016/S0140-6736(16)30506-2
15. Chiuve SE, Rexrode KM, Spiegelman D, et al. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118(9):947-
954. https://doi.org/10.1161/CIRCULATIONAHA.108.781062
16. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley and Sons. 1989.
17. Hosmer DW, Lemeshow S. Applied logistic regression. 3rd ed. New York: John Wiley and Sons. 2000.
18. El Tallawy HN, Farghaly WM, Badry R, et al. Epidemiology and clinical presentation of stroke in Upper Egypt (desert area).  Neuropsychiatr Dis Treat. 2015;11:2177-2183. https://doi.org/10.2147/NDT.S87381
19. Muchada M, Rubiera M, Rodriguez-Luna D, et al. Baseline National Institutes of Health Stroke Scale–Adjusted. Time Window for Intravenous Tissue-Type Plasminogen. Activator in Acute Ischemic Stroke. Stroke. 2014; 45(4):1059-1063. https://doi.org/10.1161/STROKEAHA.113.004307
20. Fabris F, Zanocchi M, Bo M, et al. Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke. 1994;25(6):1133-1140. https://doi.org/10.1161/01.str.25.6.1133
21. Knoflach M, Matosevic B, Rücker M, et al. Austrian Stroke Unit Registry Collaborators. Functional recovery after ischemicstroke--a matter of age: data from the Austrian Stroke Unit Registry. Neurology. 2012;78(4):279-285. https://doi.org/10.1212/ WNL.0b013e31824367ab
22. Choi JC, Lee JS, Kang SY, et al. Family history and risk for ischemic stroke: sibling history is more strongly correlated with the disease than parental history. J Neurol Sci. 2009;284(1-2):29-32. https://doi.org/10.1016/j.jns.2009.03.015
23. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiologyofischemic stroke. Stroke. 2004;35(1):212-227. https://doi.org/10.1161/01.STR.0000107187.84390.AA
24. Altafi D, Khotbesara M, Khotbesara M, et al. A comparative study OF NIHSS between ischemic stroke patients with and without risk factors. Tech J Eng Appl Sci. 2013;3(17):1954-1957.
25. Soliman RH, Oraby MI, Fathy M, et al. Risk factors of acute ischemic stroke in patients presented to Beni-Suef UniversityHospital: prevalence and relation to stroke severity at presentation. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):8. https://doi.org/10.1186/s41983-018-0012-4
26. Patlolla SH, Lee HC, Noseworthy PA, et al. Impact of Diabetes Mellitus on Stroke and Survival in Patients with Atrial Fibrillation. Am J Cardiol. 2020;131:33-39. https://doi.org/10.1016/j.amjcard.2020.06.049
27. Essa A, Helmy T, El Batch S. Study of incidence, risk factors and outcome of acute cerebrovascular stroke patients admitted to Alexandria Main University Hospital. J Am Sci. 2011;7(11):316-329.
28. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105(3):315-318. https://doi.org/10.1016/j.ijcard.2005.02.050
29. Fohtung RB, Rich MW. Identification of patients at risk of stroke from atrial fibrillation. Risk. 2016;5(12):6.
30. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA.2001;285(18):2370-2375. https://doi.org/10.1001/jama.285.18.2370
31. Bokma JP, Zegstroo I, Kuijpers JM, et al. Factors associated with coronary artery disease and stroke in adults with congenital heart disease. Heart. 2018;104(7):574-580. https://doi.org/10.1136/heartjnl-2017-311620
32. de Oliveira Diniz DL, Barreto PR, Carvalhedo de Bruin PF, et al. Wake-up stroke: Clinical characteristics, sedentary lifestyle,and daytime sleepiness. Rev Assoc Med Bras. 2016;62(7):628-634. https://doi.org/10.1590/1806-9282.62.07.628
33. Basaraba J, Picard M, George-Phillips K, et al. Pharmacists as Care Providers for Stroke Patients: A Systematic Review. Can J Neurol Sci. 2018;45(1):49-55. https://doi.org/10.1017/cjn.2017.233
34. Wang J, Wang J, Qiu S, et al. Pharmaceutical care program for ischemic stroke patients: a randomized controlled trial. Int J ClinPharm. 2021;43(5):1412-1419. https://doi.org/10.1007/s11096-021-01272-9
35. Chen Q, Jin Z, Zhang P, et al. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China. Int J Clin Pharm. 2020;42(4):1237-1241. https://doi.org/10.1007/s11096-020-01081-6

Most read articles by the same author(s)